Impact of substance use on the physical health of patients with bipolar disorder

Acta Psychiatrica Scandinavica

Volumn 121, Issue 6, 2010, Pages 437-445

  Garcia Portilla, M P ^a,b   Saiz, P A ^a,b   Benabarre, A ^b,c   Florez, G ^d   Bascaran, M T ^a,b   Diaz E M ^a,b   Bousono M ^a,b   Bobes, J ^a,b  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d SERGAS   (Spain)

Author keywords

Bipolar disorder; Cardiovascular mortality risk; Coronary heart disease; Metabolic syndrome; Substance use

Indexed keywords

ABDOMINAL OBESITY; ADULT; ARTICLE; BIPOLAR DISORDER; CANNABIS ADDICTION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRINKING BEHAVIOR; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; METABOLIC PARAMETERS; MULTICENTER STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SUBSTANCE ABUSE; TOBACCO; TOBACCO DEPENDENCE;

ADULT; BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS DISPARITIES; HEALTH STATUS INDICATORS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SELF REPORT; SEX FACTORS; SOCIOECONOMIC FACTORS; SPAIN; SUBSTANCE-RELATED DISORDERS;

EID: 77951918021     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01498.x     Document Type: Article

References (53)

1. De Hert M, Dekker JM, Wood D, Kahl KG, Möller H-J. Cardiovascular disease and diabetes in people with severe mental illness. Rev Psiquiatr Salud Ment (Barc) 2009 2 : 49 59.
2. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: Follow-up over 34-38 years. J Affect Disord 2002 68 : 167 181. (Pubitemid 34628324)
3. Baldessarini RJ, Tondo L. Suicide risk and treatments for bipolar disorder patients. JAMA 2003 290 : 1517 1519. (Pubitemid 37430410)
4. Osby U, Brandt L, Correia N, Ekbon A, Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001 58 : 844 850. (Pubitemid 32979302)
5. Torrent C, Amann B, Sánchez-Moreno J et al. Weight gain in bipolar disorder: Pharmacological treatment as a contributing factor. Acta Psychiatr Scand 2008 118 : 4 18. (Pubitemid 351832022)
6. Garcia-Portilla MP, Saiz PA, Bascaran MT et al. Cardiovascular risk in bipolar disorder patients. J Affect Disord 2009 115 : 302 308.
7. Bobes J, Saiz J, Montes JM, Mostaza J, Rico-Villademoros F, Vieta E. Spanish consensus on physical health of patients with bipolar disorder. Rev Psiquiatr Salud Ment (Barc) 2008 1 : 26 37.
8. Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990 264 : 2511 2518.
9. Weiss RD, Ostacher MJ, Otto MW et al. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry 2005 66 : 730 735. quiz 808-739. (Pubitemid 40942419)
10. Cerullo MA, Strakowski SM. The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abuse Treat Prev Policy 2007 2 : 29.
11. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001 3 : 181 188. (Pubitemid 32842743)
12. Mcelroy SL, Altshuler LL, Suppes T et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001 158 : 420 426. (Pubitemid 32205199)
13. Ringen PA, Melle I, Birkenaes AB et al. Illicit drug use in patients with psychotic disorders compared with that in the general population: A cross-sectional study. Acta Psychiatr Scand 2008 117 : 133 138.
14. Vanable PA, Carey MP, Carey KB, Maisto SA. Smoking among psychiatric outpatients: relationship to substance use, diagnosis, and illness severity. Psychol Addict Behav 2003 17 : 259 265.
15. Waxmonsky JA, Thomas MR, Miklowitz DJ et al. Prevalence and correlates of tobacco use in bipolar disorder: Data from the first 2000 participants in the Systematic Treatment Enhancement Program. Gen Hosp Psychiatry 2005 27 : 321 328. (Pubitemid 41317047)
16. Ziedonis D, Hitsman B, Beckham JC et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res 2008 10 : 1691 1715.
17. Frye MA, Altshuler LL, Mcelroy SL et al. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry 2003 160 : 883 889. (Pubitemid 41079572)
18. Feinman JA, Dunner DL. The effect of alcohol and substance abuse on the course of bipolar affective disorder. J Affect Disord 1996 37 : 43 49. (Pubitemid 26072815)
19. Salloum IM, Thase ME. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord 2000 2 : 269 280.
20. Dalton EJ, Cate-Carter TD, Mundo E, Parikh SV, Kennedy JL. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord 2003 5 : 58 61. (Pubitemid 36621635)
21. Swann AC, Dougherty DM, Pazzaglia PJ, Pham M, Steinberg JL, Moeller FG. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry 2005 162 : 1680 1687. (Pubitemid 41318238)
22. Ringen PA, Melle I, Birkenaes AB et al. The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness. Acta Psychiatr Scand 2008 118 : 297 304.
23. Mitchell JD, Brown ES, Rush AJ. Comorbid disorders in patients with bipolar disorder and concomitant substance dependence. J Affect Disord 2007 102 : 281 287. (Pubitemid 47042185)
24. Singh J, Mattoo SK, Sharan P, Basu D. Quality of life and its correlates in patients with dual diagnosis of bipolar affective disorder and substance dependence. Bipolar Disord 2005 7 : 187 191. (Pubitemid 40439479)
25. Dervaux A, Laqueille X. Tobacco and schizophrenia: therapeutic aspects. Encephale 2007 33 : 629 632.
26. Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm 2007 64 : 1917 1921.
27. Kemp DE, Gao K, Ganocy SJ et al. Medical and substance use comorbidity in bipolar disorder. J Affect Disord 2009 116 : 64 69.
28. Pickering RP, Grant BF, Chou SP, Compton WM. Are overweight, obesity, and extreme obesity associated with psychopathology? Results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2007 68 : 998 1009. (Pubitemid 47340318)
29. Mcintyre RS, Mcelroy SL, Konarski JZ et al. Substance use disorders and overweight/obesity in bipolar I disorder: Preliminary evidence for competing addictions. J Clin Psychiatry 2007 68 : 1352 1357.
30. Mcelroy SL, Frye MA, Suppes T et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002 63 : 207 213. (Pubitemid 34407079)
31. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 2008 87 : 801 809. (Pubitemid 351549222)
32. Salvi V, Albert U, Chiarle A, Soreca I, Bogetto F, Maina G. Metabolic syndrome in Italian patients with bipolar disorder. Gen Hosp Psychiatry 2008 30 : 318 323. (Pubitemid 351863767)
33. Organización Mundial De La Salud. CIE-10. Trastornos Mentales y del Comportamiento.
34. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care 2004 27 : 2444 2449. (Pubitemid 39281399)
35. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 112 : 2735 2752. (Pubitemid 41532612)
36. Conroy RM, Pyorala K, Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003 24 : 987 1003. (Pubitemid 36712275)
37. Wilson PW, D'agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998 97 : 1837 1847. (Pubitemid 28213628)
38. Hartz I, Njolstad I, Eggen AE. Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromso study 2001. Eur Heart J 2005 26 : 2673 2680. (Pubitemid 41746690)
39. Comin E, Solanas P, Cabezas C et al. Estimating cardiovascular risk in Spain using different algorithms. Rev Esp Cardiol 2007 60 : 693 702. (Pubitemid 47394947)
40. Lakka TA, Bouchard C. Physical activity, obesity and cardiovascular diseases. Handb Exp Pharmacol 2005 170 : 137 163.
41. Gonzalez-Pinto A, Gutierrez M, Ezcurra J et al. Tobacco smoking and bipolar disorder. J Clin Psychiatry 1998 59 : 225 228. (Pubitemid 28274605)
42. Itkin O, Nemets B, Einat H. Smoking habits in bipolar and schizophrenic outpatients in southern Israel. J Clin Psychiatry 2001 62 : 269 272. (Pubitemid 32428766)
43. Morris CD, Giese AA, Turnbull JJ, Dickinson M, Johnson-Nagel N. Predictors of tobacco use among persons with mental illnesses in a statewide population. Psychiatr Serv 2006 57 : 1035 1038. (Pubitemid 44036237)
44. American Psychiatric Association. Practice guideline for the treatment of patients with substance use disorders, 2nd edn. In : American Psychiatric Association, ed. American Psychiatric Disorders: Compendium 2006.
45. Ostacher MJ, Nierenberg AA, Perlis RH et al. The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry 2006 67 : 1907 1911.
46. Popik P, Krawczyk M, Kos T et al. Nicotine produces antidepressant-like actions: Behavioral and neurochemical evidence. Eur J Pharmacol 2005 515 : 128 133. (Pubitemid 40779277)
47. Strakowski SM, Delbello MP, Fleck DE et al. Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania. Arch Gen Psychiatry 2005 62 : 851 858.
48. Fan AZ, Russell M, Naimi T et al. Patterns of alcohol consumption and the metabolic syndrome. J Clin Endocrinol Metab 2008 93 : 3833 3838.
49. Bauer MS, Altshuler L, Evans DR, Beresford T, Williford WO, Hauger R. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord 2005 85 : 301 315. (Pubitemid 40386514)
50. Baethge C, Baldessarini RJ, Khalsa HM, Hennen J, Salvatore P, Tohen M. Substance abuse in first-episode bipolar I disorder: Indications for early intervention. Am J Psychiatry 2005 162 : 1008 1010. (Pubitemid 40676219)
51. Strakowski SM, Delbello MP, Fleck DE, Arndt S. The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry 2000 48 : 477 485.
52. Henquet C, Krabbendam L, De Graaf R, Ten Have M, Van Os J. Cannabis use and expression of mania in the general population. J Affect Disord 2006 95 : 103 110. (Pubitemid 46107033)
53. Leweke FM, Koethe D. Cannabis and psychiatric disorders: It is not only addiction. Addict Biol 2008 13 : 264 275. (Pubitemid 351692982)